Tenet Healthcare Corporation (THC) Stock Price, News, Analysis

Technical Score (1D)

BUY

News Sentiment

MIXED

Tenet Healthcare’s Q2 results are now available, but there is conflicting information about whether the earnings release has already occurred, creating uncertainty for traders. The reported revenue of $5.37 billion matched analysts’ 2.8% YoY growth forecast, suggesting the company’s top‑line trajectory is on track. Earnings per share beat estimates, which could lift investor confidence in the company’s profitability. However, the full‑year revenue guidance fell slightly below expectations, raising concerns that growth may slow in the coming quarters. The company’s historical tendency to miss revenue estimates remains a risk factor that could weigh on the stock if the guidance is not met. Because the earnings announcement is scheduled for Friday before the market opens, traders should monitor the release for any deviation from the current guidance. A stronger‑than‑expected full‑year outlook could support the share price, while a weaker outlook could trigger a sell‑off. Watch for any updates on cost control measures or changes in payer mix that could influence future earnings. Also keep an eye on broader healthcare reimbursement trends, as shifts in policy could impact Tenet’s revenue mix in the next 1–10 trading days.

THC|Company Info

Sector

Healthcare

Industry

Medical Care Facilities

Exchange

NYQ

Country

United States

Website

tenethealth.com

Symbol

THC

Description

Tenet Healthcare Corporation is a U.S.-based healthcare services provider operating through two primary segments: Hospital Operations and Services, and Ambulatory Care. The company's core value proposition lies in its comprehensive network of acute care hospitals, offering a wide array of services including surgery, radiology, and specialized treatments for various conditions. These hospitals also provide intensive care, specialized surgical procedures, and tertiary care services. Furthermore, Tenet expands its reach through ambulatory surgery centers, urgent care facilities, and imaging centers, providing convenient access to outpatient care. Founded in 1967, the company's diversified service offerings and extensive physical footprint are key elements of its competitive positioning within the healthcare landscape.

THC|Earnings Snapshot

Earnings Summary

Tenet Healthcare Corporation is a U.S. provider of hospital and ambulatory services, operating a broad network of acute care hospitals and outpatient centers that deliver surgery, radiology, and specialty care, positioning it as a diversified player in the medical care facilities sector. In the most recent reporting period, Tenet posted EPS of $4.70 in Q4 2025, up from $3.44 in Q4 2024, and revenue of $5.527 billion, matching the $5.527 billion estimate; the company beat estimates in both quarters, while Q4 2024 also surpassed its $2.832 estimate, underscoring a strong earnings trajectory. Historically, Tenet’s revenue has grown YoY, rising from $5.072 billion in Q4 2024 to $5.527 billion in Q4 2025, and EPS has increased from $3.44 to $4.70, reflecting consistent profitability gains; however, the upcoming Q2 2026 results are pending, leaving a gap in the trend. Recent analyst commentary, including Bank of America’s reaffirmation of a Buy rating with a trimmed $230 target and BMO Capital’s Outperform rating at $159, highlights confidence in Tenet’s cash generation and margin maintenance while noting payer‑mix concerns and labor‑cost pressures; the notes also emphasize the importance of cost‑control initiatives and potential acquisitions for sustaining growth. The July 24 earnings release is expected to report an EPS of $4.08 and revenue of $5.39 billion, testing Tenet’s ability to sustain Q1 momentum and meet full‑year guidance of $17.61 per share and $22.02 billion in sales. Investors should watch the forthcoming Q2 2026 earnings for guidance on revenue and margin trends, any updates on payer‑mix negotiations or labor‑cost adjustments, and signals from technology investments such as AI‑driven predictive analytics that could influence operating efficiency and future profitability.

Read full report

EPS

EstBeatMiss

Qtr	Est	Actual	+/−
Q2'26	$4.26	-	-
Q4'25	$4.09	$4.70	+14.8%
Q4'24	$2.83	$3.44	+21.5%

Revenue

EstBeatMiss

Qtr	Est	Actual	+/−
Q2'26	$5.5B	-	-
Q4'25	$5.5B	$5.5B	+0.0%
Q4'24	-	$5.1B	-

Full Earnings BreakdownEstimates, actuals, guidance, and historical context

→

Market Data

THC Stock Snapshot

THC is currently trading at $225.00, giving Tenet Healthcare Corporation a market cap of 16.93B and a P/E ratio of 9.9. Today's range spans $191.76–$232.99, with shares opening at $194.48 and moving up $25.91 (13.0%) from the prior close. DailyIQ's technical score sits at 82/100 (BUY) with a news sentiment reading of 53/100.

Over the past year THC has traded between $146.60 and $247.21 - the current price is +53.5% off the 52-week low and -9.0% from the high. 29 analysts cover the stock with a Buy consensus and a mean 12-month target of $243.43 (range $210.00–$288.00), implying upside of +8.2%.

Relative strength is the story for Tenet Healthcare Corporation (THC) in Healthcare right now. Technical score 82/100 (BUY), sentiment neutral at 53/100, price $225.00 (in the upper portion of its 52-week range). The current P/E ratio stands at 9.9. The 16.93B market cap keeps this name on institutional screens, and the bullish setup means sector rotation inflows from Healthcare have a natural landing spot here. Annual range: $146.60–$247.21.

Earnings revision cycles in large-cap Healthcare names tend to compound: when technicals confirm a BUY thesis (82/100) and news sentiment (53/100, neutral) supports the narrative, analyst upgrades follow price rather than lead it. At $225.00 (in the upper portion of its 52-week range), THC's position within the $146.60–$247.21 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.

News Sentiment Analysis

Sentiment gathered from recent headlines

53/100

Strong NegativeNeutralStrong Positive

MIXED

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

No summary available yet for this article.

What did this article say?

Tenet Healthcare will report earnings this Friday before the market opens. Analysts anticipate revenue growth of 2.8% year‑over‑year, aligning with last year’s 3.3% increase. The company has historically missed revenue estimates, but recent guidance suggests a steady trajectory. Traders should monitor the earnings release for any deviation from expectations.

What did this article say?

Argus Research has lowered its rating on THC to a HOLD, citing concerns over margin pressure and a weaker earnings outlook for the upcoming quarter. The downgrade signals potential downside risk for the stock and reflects a more cautious view of the company’s near‑term profitability. Traders should watch the forthcoming earnings release and any guidance updates for further clues on the company’s trajectory.

What did this article say?

THC reported that Q2 patient days were lower than expected, but the company saw higher revenue per admission and growth in ambulatory care services. The reduced inpatient volume could pressure earnings, yet the improved per‑patient revenue and outpatient expansion may mitigate the impact. Investors should monitor the trajectory of ambulatory care growth and any further changes in patient day trends.

What did this article say?

Guggenheim analyst Jason Cassorla has kept a Buy recommendation on Tenet Healthcare (NYSE:THC) while trimming the price target from $252 to $242. The downgrade reflects concerns about the company’s earnings trajectory and competitive pressures in the healthcare sector. The rating suggests that the firm still sees upside potential but at a lower valuation ceiling. Traders should note the updated target as a new benchmark for performance expectations.

What did this article say?

Tenet Healthcare's valuation remains below perceived fair value according to Simply Wall St. The analysis highlights potential upside for investors, suggesting the stock may be undervalued relative to its fundamentals. The upcoming earnings release on July 24, 2026 could confirm or adjust this valuation assessment. Investors should monitor earnings guidance and analyst revisions for further insight.

What did this article say?

Tenet Healthcare is approaching its earnings release with a focus on its undervalued narrative. Analysts anticipate modest changes in earnings per share and revenue. Recent revisions have trimmed EPS expectations, and the stock holds a Zacks Rank of #3 (Hold). Investors should watch for earnings guidance and any shifts in analyst sentiment.

What did this article say?

Tenet Healthcare (THC) ended the session at $194.91, a 2.15% decline that outpaced the S&P 500’s 1.01% loss. The hospital operator’s shares had risen 15.43% in the last month, but the recent dip mirrors broader market weakness. The company is slated to report earnings on July 24, with analysts forecasting an EPS of $4.08 and quarterly revenue of $5.39 billion, both up YoY. Consensus estimates indicate modest year‑over‑year gains, suggesting a stable outlook.

What did this article say?

Bank of America reaffirmed a Buy rating on Tenet Healthcare, trimming its price target to $230 while citing a more conservative view of hospital valuations amid payer mix concerns. Despite the target cut, the analyst highlighted Tenet’s robust cash generation and ample liquidity, positioning the company to continue investing, deleverage, and return capital to shareholders. The stock rose 4.4% in the afternoon session, reflecting market confidence in the company’s fundamentals.

What did this article say?

The Q1 earnings cycle concluded with a comparative analysis of hospital chain stocks, spotlighting Tenet Healthcare (THC). Tenet's performance was evaluated against peers, highlighting relative strengths and weaknesses in revenue growth, operating margins, and debt levels. The review underscores how Tenet's financial metrics stack against industry benchmarks, offering insight into its valuation and future earnings trajectory.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

No summary available yet for this article.

What did this article say?

THC·Tenet Healthcare Corporation

EPS

Revenue

THC Stock Snapshot

News Sentiment Analysis

Recent News Coverage

Discover More

News Sentiment Analysis

Recent News Coverage

Discover More